138 related articles for article (PubMed ID: 17400564)
21. Intravenous iron sucrose changes the intraperitoneal homeostasis.
Breborowicz A; Połubinska A; Kupczyk M; Wanic-Kossowka M; Oreopoulos DG
Blood Purif; 2009; 28(1):53-8. PubMed ID: 19325240
[TBL] [Abstract][Full Text] [Related]
22. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
23. Low cholesterol along with inflammation predicts morbidity and mortality in hemodialysis patients.
Tsirpanlis G; Boufidou F; Zoga M; Triantafyllis G; Fatourou A; Stamatelou K; Bleta A; Petrihou C; Chatzipanagiotou S; Nicolaou C
Hemodial Int; 2009 Apr; 13(2):197-204. PubMed ID: 19432694
[TBL] [Abstract][Full Text] [Related]
24. Increased dialyzer reuse with citrate dialysate.
Ahmad S; Callan R; Cole J; Blagg C
Hemodial Int; 2005 Jul; 9(3):264-7. PubMed ID: 16191076
[TBL] [Abstract][Full Text] [Related]
25. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
Movilli E; Viola BF; Camerini C; Mazzola G; Cancarini GC
J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
[TBL] [Abstract][Full Text] [Related]
26. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
27. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
28. Peritoneal small solute transport rate is related to the malnutrition inflammation score in peritoneal dialysis patients.
Sezer S; Elsurer R; Afsar B; Arat Z; Ozdemir NF; Haberal M
Nephron Clin Pract; 2007; 107(4):c156-62. PubMed ID: 17957127
[TBL] [Abstract][Full Text] [Related]
29. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress and ferritin levels in haemodialysis patients.
Senol E; Ersoy A; Erdinc S; Sarandol E; Yurtkuran M
Nephrol Dial Transplant; 2008 Feb; 23(2):665-72. PubMed ID: 18039638
[TBL] [Abstract][Full Text] [Related]
31. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
[TBL] [Abstract][Full Text] [Related]
32. [Chronic inflammation, oxidative stress and effects of erythropoetin in end-stage renal disease patients].
Lazarević T; Stojimirović B; Poskurica M; Lazarević M; Mitrović N; Stolić R
Med Pregl; 2007; 60 Suppl 2():109-13. PubMed ID: 18928173
[TBL] [Abstract][Full Text] [Related]
33. Dialysis-related systemic microinflammation is associated with specific genomic patterns.
Zaza G; Pontrelli P; Pertosa G; Granata S; Rossini M; Porreca S; Staal FJ; Gesualdo L; Grandaliano G; Schena FP
Nephrol Dial Transplant; 2008 May; 23(5):1673-81. PubMed ID: 18048420
[TBL] [Abstract][Full Text] [Related]
34. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
Hamlett L; Haragsim L
Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
[TBL] [Abstract][Full Text] [Related]
35. Ultrapure dialysate: facts and myths.
Bommer J; Jaber BL
Semin Dial; 2006; 19(2):115-9. PubMed ID: 16551288
[TBL] [Abstract][Full Text] [Related]
36. A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea-190H) to a standard high flux polysulfone dialyser membrane (FX-80) in the setting of extended hours haemodialysis.
Kameshwar K; Damasiewicz MJ; Polkinghorne KR; Kerr PG
Nephrology (Carlton); 2022 Jun; 27(6):494-500. PubMed ID: 35195932
[TBL] [Abstract][Full Text] [Related]
37. Serum albumin, body weight and inflammatory parameters in chronic hemodialysis patients: a three-year longitudinal study.
Bossola M; La Torre G; Giungi S; Tazza L; Vulpio C; Luciani G
Am J Nephrol; 2008; 28(3):405-12. PubMed ID: 18087147
[TBL] [Abstract][Full Text] [Related]
38. Association of high-flux dialysers and bacterial contamination of dialysate-induced chronic release of cytokines in haemodialysis patients.
Perez-Garcia R; Anaya F; Chisvert J; Valderrabano F
Nephrol Dial Transplant; 1995 Nov; 10(11):2164-6. PubMed ID: 8643200
[No Abstract] [Full Text] [Related]
39. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
40. Lack of appetite in haemodialysis patients--associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS.
Lopes AA; Elder SJ; Ginsberg N; Andreucci VE; Cruz JM; Fukuhara S; Mapes DL; Saito A; Pisoni RL; Saran R; Port FK
Nephrol Dial Transplant; 2007 Dec; 22(12):3538-46. PubMed ID: 17893106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
